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Aim: To determine the effect of a health coach intervention for the management of
glycemic control, as well as physiological, psychological and self-care outcomes of
patients with type 2 diabetes mellitus (T2DM), compared with usual care.
Methods: This pragmatic cluster RCT was conducted in the Fengtai district of Beijing
from August 2011 to December 2013. Forty-one community health stations (CHSs)
were cluster randomized (stratified geographically, 1:1 ratio) and eligible, randomly
selected T2DM patients were sequentially contacted by CHSs. Control participants
received usual care according to the Chinese Guideline for Diabetes Prevention and
Management. Intervention participants received 18-months of health coaching based
on principles of Motivational Interviewing (MI) plus usual care. Medical and pathology
fees were waived for both groups. Outcome assessment was performed at baseline, 6,
12, and 18-months. The primary outcome was glycated hemoglobin (HbA1c); secondary
outcomes encompassed a suite of physiological, psychological and self-care measures.
Results: No differential treatment effect was found at 18-months for HbA1c (adj.
difference −0.07, 95% CI −0.53 to 0.39, p = 0.769) or any specified secondary
outcomes. Interestingly, both groups displayed a statistically and clinically significant
within-group improvement of the same magnitude at 18-months for HbA1c (intervention:
mean change −3.65, 95% CI −3.92 to −3.37; control: mean change −3.38, 95% CI
−3.67 to −3.08).
Conclusions: The lack of differential treatment effects observed indicate that it may be
premature to recommend the routine delivery of health coach interventions based on
MI principles for the management of T2DM in China. However, the large, comparable
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within-group improvement in mean HbA1c promotes the establishment of free, regular
clinical health assessments for individuals with T2DM in China.
Trial Registration: ISRCTN registry - ISRCTN01010526 (https://doi.org/10.1186/
ISRCTN01010526)
Keywords: type 2 diabetes, China, health coaching, motivational interviewing, cluster randomized controlled trial,
pragmatic trial
INTRODUCTION
Diabetes Mellitus (DM) has emerged as a global health concern
affecting ≥425 million adults worldwide (1), and an astonishing
25% of these are individuals in China. Recent estimates indicate
that 114.4 million adults in China had DM in 2017, and this
is projected to reach 119.8 million by 2045 (1). Such large and
increasing numbers of DM pose significant challenges to the
Chinese health care system, with direct annual costs recently
estimated to be Int$170 billion (2). Effective DM management
approaches are therefore key goals for China.
Type 2 diabetes mellitus (T2DM), the most prevalent form
of DM, “is a complex, chronic condition that requires effective
long-term medical management to prevent or postpone chronic
complications” (3). To ensure individuals with T2DM receive
the wide range of support that is required to manage the
physical, psychological and social impacts of their condition, the
combination of high-quality clinical care, and self-management
support are fundamental (4). However, in China, T2DM
management approaches are generally not patient-centered.
Alternatively, doctors in China predominantly focus on the
pharmaceutical management of T2DM, and generally disregard
the facilitation of behavior change to control T2DM-related
outcomes (5).
China is currently in the process of major health system
reform, and the delivery of health care to individuals with
T2DM is in transition. A key focus of these reforms is the
establishment of a community-based primary health care system
that is affordable, accessible and of high-quality (6). The most
recent version of the Chinese Guideline for Diabetes Prevention
and Management supports these reform goals by prioritizing
the long-term management of T2DM, shifting away from an
acute-centered care model that has traditionally been delivered
by Chinese hospitals (7). The guideline further recommends the
delivery of psychological care to assist individuals in adjusting
to a new-diagnosis, and to support adherence to lifestyle
changes (7).
A number of T2DM management approaches have been
implemented internationally to support individuals in the
self-management of their condition. The utilization of peer
support programs (8), web-based interventions (9), diabetes
self-management education programs (10), and psychological
interventions (11) have all been found to have direct benefits for
individuals with T2DM. A recent meta-analyses of randomized
controlled trials (RCTs) in China similarly supported the use
of psychological therapies, namely cognitive behavioral therapy,
client-centered therapy, and motivational interviewing (MI) for
the improvement of glycemic and psychological outcomes of
T2DM (12). However, only three studies were included in the
meta-analysis for MI (13–15); validity, as assessed through risk
of bias (16), was unclear for the majority of included studies;
and only two studies utilizing MI were conducted within the
community health setting (14, 17).
Given the lack of methodologically robust studies utilizing
MI within the community health sector in China, and the
Chinese governments’ strong commitment to primary care
reform, this study aimed to assess the effectiveness of a T2DM
management intervention that utilized health coaches trained
in MI within an urban community health setting in China.
Based on findings observed in previous meta-analyses (11, 12),
it was hypothesized that compared to usual care, the structured
health coach intervention would lead to improved physiological,
psychological, and self-care T2DM-related outcomes. This paper
will report on the final outcome assessment of the trial at 18-
months; results of both the pilot study (18) and 12-month pre-
results (19) are available elsewhere.
METHODS
Trial Design and Participants
A pragmatic, cluster RCT design was implemented from August
2011 to December 2013 within Community Health Stations
(CHSs) in the Fengtai district of Beijing, China. This district
lies to the southwest of central Beijing and covers an area of
approximately 305 km2 (20). The utilization of a cluster design
was primarily selected to minimize experimental contamination
between individuals in the control and intervention groups
(health professionals & participants). The study protocol was
approved by the Monash University Human Research Ethics
Committee (CF11/2657 - 2011001550). All participants gave
written informed consent in accordance with the Declaration of
Helsinki.
All government-owned and administered CHSs in Fengtai
district were identified as eligible clusters, resulting in an overall
cluster sample size of 42 CHSs. Prior to randomization, consent
for CHS participation was obtained from the Fengtai Health
Bureau, the body which governs all eligible CHSs.
To reduce risk of recruitment bias, eligible participants
were identified and recruited prior to cluster randomization. A
blinded, independent person at each of the 42 CHSs identified
eligible participants from medical records. Patients with an
established T2DM diagnosis were eligible if they were receiving
care at a participating CHS; aged ≥50 years; and lived in
Fengtai. Exclusion criteria included a medical condition that
precluded adherence to recommendations (e.g., terminal cancer),
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or the inability to provide informed consent. No additional
exclusion criteria were applied due to the pragmatic nature of the
trial.
Sample Size
Sample size calculations have previously been reported (19).
In brief, sample estimates assumed 42 clusters, a participant
attrition rate of 20%, intracluster correlation coefficient of 0.05,
power at 80%, alpha of 0.05, and an expected standardized
effect of 0.32 for the primary outcome (HbA1c) measured on
a continuous scale. This estimated a total of 726 participants
were required. Small CHSs aimed to recruit 15 participants,
while large stations aimed to recruit 25 participants per
station. Consequently, the overall number of participants
targeted for recruitment was 780 (control: 395: intervention:
385).
Stratification and Randomization
Eligible participants from each CHS were firstly stratified by
gender to achieve a balance of men and women. This was
performed as gender-specific health disparities have previously
been observed among individuals of Chinese descent with regard
to DMmanagement and DM-related outcomes (21). Participants
were then randomly sampled by computerized random allocation
software, resulting in an ordered list of participants (for each
CHS; by gender) to be contacted for consent. Because the socio-
demographic profile of individuals residing in Fengtai varies
according to locality, CHSs were then stratified by geographic
location to achieve a balance of groups. Prior to cluster
randomization, one CHS permanently shut down; resulting in
a total of 41 CHSs available for randomization. Clusters were
randomized into control (n= 20) or intervention (n= 21) groups
using block randomization by computerized random allocation
software. This procedure was performed at a central location by
an independent person, and all clusters were coded to ensure the
block randomization was blinded.
Participant Recruitment
To ensure the required participant sample size was met after
the closure of one CHS, one neighboring CHS was required to
recruit double the participant numbers (i.e., 30 instead of 15).
A recruitment officer at each CHS sequentially contacted and
invited individuals to participate in the study. If an individual
declined, the reason provided was to be recorded.
All interested participants were provided with a consent form
and explanatory statement. Once consent forms were received,
participants were allocated an identification number and were
instructed to return to their CHS for the baseline clinical health
assessment at a specified date and time.
Participants were notified that payment would not provided
for participation in the study, but medical fees (consultation
and pathology fees) associated with the study would be waived.
Despite China having near-universal health insurance coverage,
individuals commonly experience out-of-pocket expenses for
both pharmaceutical and medical care (22).
Outcome Assessment
Patient level outcomes were assessed at baseline, 6, 12, and 18-
months via a clinical health assessment and an interviewer-
administered questionnaire. An interviewer-administered mode
was chosen in preference to a self-administered mode due to
potential literacy problems within the participant group. In
2010, 26.09% of Chinese adults aged >65 were estimated to be
illiterate (23).
The primary outcome measure was glycated hemoglobin
(HbA1c). Secondary physiological outcomes included weight,
body mass index (BMI), systolic and diastolic blood pressure
(BP), waist and hip circumference, and fasting blood samples
[fasting plasma glucose (FPG), triglycerides, and total, high-
density lipoprotein (HDL), and low-density lipoprotein (LDL)
cholesterol]. The suite of psychological and self-care secondary
outcome measures comprised psychological distress [Kessler
10 (K10)], quality of life (WHOQoL-BREF), diabetes self-care
activities (SDSCA), and diabetes management self-efficacy (C-
DMSES). All outcomes were assessed by CHS doctors and nurses
specifically trained in data collection for the trial, according to
the study protocol (24) (except LDL cholesterol, which utilized
a direct method). The classification of elevated physiological
outcomes was based on specified information within the Chinese
diabetes guidelines (7). Participants in both treatment groups
were informed of their physiological results following each
assessment.
Participants were asked to fast overnight prior to each clinical
health assessment for ≥8 h. Due to the pragmatic nature of
this trial, data collectors were unblinded to group allocation;
however, laboratory technicians were blinded. Analysis of all
blood samples was performed at the Fengtai Center for Disease
Control and Prevention Laboratory, which has certification from
the National Center for Clinical Laboratories of China.
Intervention
Control Group
Participants in the control group received usual care only
from their CHS. Usual care referred to the standard care as
specified in the Chinese Guideline for Diabetes Prevention and
Management (7). Although usual care is naturally expected to
vary in pragmatic trials between providers and patients, and
according to institutional policies, the recommended schedule
outlined within the Chinese guideline involves quarterly doctor
consultations and biannual physical examinations that include
the assessment of HbA1c. The guideline also includes referral
to health professionals from multiple disciplines. In order to
meet the data collection requirements for this trial, an increase
in monitoring was necessary (in addition to that outlined in the
guidelines).
Intervention Group
Participants in the intervention group received a combination of
face-to-face and telephone health coaching, plus usual care from
their CHS. The health coaching was delivered by experienced
clinicians (community nurses, doctors, and psychologists)
from each CHS. Before commencing the intervention, health
coaches completed a Monash University certified training
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program in coach-assisted chronic disease management. This
entailed a pre-workshop learning phase which included the
study of key concepts in patient-centered communications,
health psychology, epidemiology of key targeted illnesses and
conditions, MI and behavior change, program evaluation, clinical
outcome measurement, and the intervention protocol (24).
This was followed by a 2-day intensive MI workshop that
introduced health coaches to the rationale and framework of
MI, and involved the application of core MI skills throughout
the behavior change process. This workshop was conducted
by a member of the Motivational Interviewing Network of
Trainers (25). The workshopwas delivered face-to-face in English
and an interpreter was used to communicate the content in
Mandarin. To ensure health coaches were supported in their
MI skill development, refresher workshops were also conducted
throughout the 18-month intervention phase. One month
after the intervention commenced, health coaches received an
additional half-day advanced workshop and were contacted on
a quarterly basis for feedback and debriefing.
Health coaches aimed to support participants in achieving
the management targets as specified within the Chinese diabetes
guidelines (7), with the management of HbA1c <7% being
of primary focus. An intervention manual was used to guide
health coaches in utilizing existing local recommendations and
guidelines. Variation in intervention delivery was expected due to
the pragmatic nature of the trial and the need for health coaches
to adapt the manual to local contexts.
The first requirement of each health coaching session involved
setting the agenda with participants. This was accomplished
by asking the participant to determine the most productive
place to start the discussion. Once a key issue was identified,
health coaches guided the discussion with the fundamental
aim of enhancing the participants internal motivation and
commitment for change. Initially, participants received two
telephone and two face-to-face coaching sessions per month.
Session frequency decreased over the 18-month trial period, as
depicted in Figure 1.
Statistical Analysis
Statistical analysis was performed using Stata software (v12.0)
and a significance level of p < 0.05 was used to evaluate
statistical significance for both primary and secondary outcomes.
Descriptive statistics were used to summarize characteristics
(baseline and patterns of mean change over time) of both CHSs
and participants. Differences between control and intervention
conditions, on all outcomes, were evaluated using multilevel
modeling analysis. Specifically, multilevel mixed effects models
with robust standard errors were used to assess all continuous
outcomes, implemented with the xtmixed command. Random
effects accounted for within-patient correlation and within-
site clustering. Fixed effects included intervention group
and time. Primary analysis assessed 6, 12, and 18-month
changes in HbA1c. Secondary analyses included all pre-specified
continuous outcomes. Model fit was evaluated by comparing AIC
values.
Models were adjusted for an a priori set of baseline
variables, consisting of gender, highest education level, chronic
comorbidity category, age group, time since diabetes diagnosis,
and residential address socioeconomic status (specific categories
provided below Tables 2, 3). Between-group effects were then
calculated for all outcomes using the lincom command. This
procedure estimates an adjusted difference in mean scores
between the two treatment groups and its 95% confidence
interval. One-way analysis of variance tests were used to estimate
ICCs. A missing data analysis was done for each outcome,
which consisted of Little’s MCAR test to examine patterns of
missingness in variables of baseline characteristics and group
allocation (Table 1).
RESULTS
Between August 22, 2011, and November 15, 2011, 753
participants were recruited into the trial. The trial flow for
CHSs and participants is depicted in Figure 2. Of the 20
CHSs randomized to the control condition, two CHSs did not
recruit participants according the study protocol. This led to
inaccurate ID allocation of participants, and these clusters were
subsequently removed from the study prior to baseline data
collection (23 participants). Therefore, 39 CHSs [18 control CHSs
(345 participants) and 21 intervention CHSs (385 participants)]
were included in the study. No additional CHSs were lost to
follow-up throughout the 18-month trial.
Prior to baseline data collection, 19 participants (intervention:
n = 13; control: n = 6) withdrew and did not commence the
study. Of the 711 participants (intervention: n = 372; control:
n = 339) who participated in baseline data collection, 588
(intervention: n = 322; control: n = 266) were included in the
analysis at 18-months. The participant attrition from baseline was
17.3% (intervention: 13.4%; control: 21.5%). Analysis of missing
data showed that dropouts were missing completely at random
(Little’s MCAR test: Chi-Square= 19.4, df= 18, p= 0.4).
Baseline data were obtained from 39 CHSs (21 intervention;
18 control) and 711 participants (372 intervention; 339 control)
(Table 1). The two trial arms were balanced for all variables at
both the cluster and participant level.
With regard to the characteristics of CHSs, the mean
population of CHS zone in the intervention and control group
was 19,025 ± 10,553 and 23,884 ± 29,994, respectively. The
mean number of annual CHS visits was 18,198 ± 16,572 for
intervention CHSs and 30,862 ± 42,075 for control CHSs. The
doctor to nurse ratio was approximately 1:1 (intervention: 2.9 ±
2.0:3.1± 1.8; control: 3.2± 2.3: 2.9± 1.2) and the mean number
of years since CHS establishment was >10 years for both groups
(intervention: 13.5± 6.0; control: 11.4± 4.9).
At the participant level, mean age for both groups was
approximately 64 years (intervention: 63.7 ± 7.6; control:
64.0 ± 9.0); and there were slightly more women in the
sample (intervention: 51.3%, 191/372; control: 54.3%, 184/339)
than men. The majority of participants in both groups were
married (intervention: 91.1%, 338/371; control 88.5%, 299/338),
had received secondary school education (intervention: 71.5%,
266/372; control: 65.7%, 222/338), and were retired (intervention:
92.7%, 343/370; control: 91.4%, 309/338). Mean T2DM duration
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FIGURE 1 | Graphical representation of interventions for each treatment condition.
for both groups was approximately 10 years (intervention: 10.0
± 6.5; control: 9.6 ± 6.6) and roughly one third of participants
were prescribed insulin at baseline (intervention: 33.4%, 124/371;
control: 29.4%, 99/337).Additionally, the majority of participants
in both groups had chronic co-morbid conditions present at
baseline (intervention: 84.9%, 316/372; control: 79.1%, 268/339)
and approximately one-fifth of participants were categorized as
current smokers (intervention: 18.5%, 68/367; control: 20.2%,
65/321).
Table 2 shows the primary and secondary physiological
outcomes; Table 3 the secondary psychological and self-
care outcomes. At 18-months, no significant between-group
differences were found for the primary outcomemeasure, HbA1c
(adj. difference −0.07, 95% CI −0.53 to 0.39, p = 0.769), with
both intervention and control groups displaying statistically
significant improvements (intervention: mean change−3.65, 95%
CI−3.92 to−3.37; control: mean change−3.38, 95% CI−3.67 to
−3.08). Similarly, no differential treatment effects were found at
18-months for any of the secondary physiological, psychological
or self-care outcome measures. However, both groups displayed
statistically significant within-group improvements at 18-months
in FPG (intervention: mean change −0.83, 95% CI −1.19 to
−0.47; control: mean change −0.98, 95% CI −1.37 to −0.59),
triglycerides (intervention: mean change −0.34, 95% CI −0.50
to −0.17; control: mean change −0.20, 95% CI −0.37 to −0.03),
total cholesterol (intervention: mean change−0.58, 95% CI−0.72
to −0.44; control: mean change −0.61, 95% CI −0.77 to −0.45),
HDL cholesterol (men—intervention: mean change +0.18, 95%
CI 0.13 to 0.23; control: mean change +0.16, 95% CI 0.10 to
0.22: women—intervention: mean change +0.09, 95% CI 0.04 to
0.14; control: mean change +0.11, 95% CI 0.05 to 0.16), LDL
cholesterol (intervention: mean change −0.53, 95% CI −0.67 to
−0.39; control: mean change−0.55, 95% CI−0.70 to−0.40), and
SDSCA-Blood Glucose Monitoring (intervention: mean change
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TABLE 1 | Baseline characteristics of CHSs and participants by study group.
Baseline characteristics Intervention group Control group
Community Health Stations, n (%): 21 (53.8%) 18 (46.2%)a
Population of CHS zone, mean ± SD 19,025 ± 10,553 23,884 ± 28,994
Number of annual CHS visits, mean ± SD (median) 18,198 ± 16,572 (19,631) 30,862 ± 42,075 (18,730)
Number of CHS doctors, mean ± SD 2.9 ± 2.0 3.2 ± 2.3
Number of CHS nurses, mean ± SD 3.1 ± 1.8 2.9 ± 1.2
Years since CHS establishment, mean ± SD 13.5 ± 6.0 11.4 ± 4.9
Participants, n (%): 372 (52.3%) 339 (47.7%)
Age in years, mean ± SD (median) 63.7 ± 7.6 (62.2) 64.0 ± 9.0 (63.7)
Female, n (%): 191/372 (51.3%) 184/339 (54.3%)
Married (including de facto), n (%): 338/371 (91.1%) 299/338 (88.5%)
Retired, n (%): 343/370 (92.7%) 309/338 (91.4%)
Secondary/high school education, n (%): 266/372 (71.5%) 222/338 (65.7%)
Duration of T2DM in years, mean ± SD 10.0 ± 6.5 9.6 ± 6.6
Currently prescribed insulin, n (%): 124/371 (33.4%) 99/337 (29.4%)
Co-morbid conditions present, n (%): 316/372 (84.9%) 268/339 (79.1%)
Current Smoker, n (%): 68/367 (18.5%) 65/321 (20.2%)
Differences in the participant n denominator for some baseline variables are a consequence of missing data.
aMeans and SDs for control CHSs based on n = 17. One CHS was an extreme outlier for all variables and subsequently removed for analysis. Baseline characteristics of the excluded
CHS are as follows: Population of CHS zone−120,567; Number of annual CHS visits−420,827; Number of CHS doctors−46; Number of CHS nurses−32; Years of CHS establishment
−56.
+0.78, 95% CI 0.50 to 1.06; control: mean change +0.73, 95% CI
0.42 to 1.03).
Additional within-group significant changes were observed
between baseline and 18-months that were not consistent among
both treatment groups. With regard to physiological outcomes
at 18-months, only intervention participants displayed small
yet statistically significant improvements in systolic BP (mean
change +0.84, 95% CI 0.46 to 1.22); while statistically significant
improvements in weight (mean change −1.99, 95% CI −3.74 to
−0.24), BMI (mean change −0.27, 95% CI −0.48 to −0.05), and
hip circumference for women (mean change−1.79, 95%CI−3.19
to −0.40) were only observed within participants in the control
group.
Significant within-group deteriorations in the mean between
baseline and 18-months were observed among intervention
participants only for a considerable number of psychological
outcomes, namely psychological distress (mean change +1.72,
95% CI 0.80 to 2.63), C-DMSES (mean change −4.90, 95% CI
−9.32 to −0.48), and the WHOQoL-BREF domains of physical
(mean change −3.09, 95% CI −4.75 to −1.43), psychological
(mean change −7.69, 95% CI −9.94 to −5.44), and environment
(mean change −5.72, 95% CI −7.99 to −3.45). In contrast,
a statistically significant within-group improvement in the
SDSCA-Foot Care subscale at 18-months was observed among
participants in the control group only (mean change +0.84, 95%
CI 0.46 to 1.22).
DISCUSSION
This study is the first pragmatic cluster RCT to examine the
effectiveness of a health coach intervention for the management
of physiological, psychological and self-care outcomes of T2DM
within the community health sector in China, relative to usual
care. The findings obtained found no differential treatment effect
for HbA1c or for a series of physiological, psychological or
self-care secondary outcomes. As such, the study hypothesis was
not supported.
Chief among the key findings observed were the significant
within-group improvements in mean HbA1c between baseline
and 18-months for participants from both treatment groups.
In addition to being statistically significant, the comparable
change in mean HbA1c from approximately 10% at baseline to
within the optimal range of <7.0% at 18-months, is of clinical
significance. Glycemic control is central to T2DM management,
and evidence from various landmark studies indicate that lower
HbA1c levels are associated with delayed onset or progression of
microvascular complications (26). Epidemiological analyses have
further revealed a curvilinear relationship between HbA1c and
microvascular complications (27). This relationship indicates
that the greatest number of complications will be prevented, at a
population level, by shifting individuals from very poor glycemic
control to fair/good glycemic control. The improvements
observed for HbA1c in the present study, if sustained, therefore
have the potential for reductions to be noted in microvascular
complications.
Although significant within-group changes were noted for
numerous secondary outcomes at 18-months, it is unlikely
that any of the observed changes will translate into clinical
significance. The magnitude of mean change was relatively small
for all secondary outcomes; mean values for the majority of
statistically significant physiological outcomes remained outside
of optimal range at 18-months (except triglycerides and HDL
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FIGURE 2 | CONSORT flow diagram of community health stations and participants through the 18-month trial. Differences in the participant n values for the primary
and secondary outcomes at 18-months are due to missing/invalid data.
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TABLE 2 | Physiological outcomes at baseline and 18 months by study group.
Intervention group Control group Available cases analysis
Outcomes N Mean ± SD N Mean ± SD ICCa Adjusted difference
between
change scores (95% CI)b
P-value
PRIMARY OUTCOME
HbA1c (%)
Target: <7.0%
Baseline 359 10.60 ± 2.09 323 10.29 ± 1.71
18 months 302 6.94 ± 1.65 242 6.99 ± 1.70
Mean change from baseline
to 18 months (95% CI)
−3.65 (−3.92 to −3.37) −3.38 (−3.67 to −3.08) 0.33 −0.07 (−0.53 to 0.39) 0.769
SECONDARY OUTCOMES
Weight (kg)
Baseline 359 70.13 ± 11.71 333 69.68 ± 10.27
18 months 283 69.14 ± 11.13 236 67.82 ± 9.77
Mean change from baseline
to 18 months (95% CI)
−0.39 (−0.85 to 0.06) −0.74 (−1.29 to −0.18) 0.06 0.34 (−0.58 to 1.26) 0.469
BMI (kg/m2)
Target: <24 kg/m2
Baseline 359 26.23 ± 3.69 333 26.03 ± 3.42
18 months 283 25.90 ± 3.42 236 25.64 ± 3.37
Mean change from baseline
to 18 months (95% CI)
−0.15 (−0.32 to 0.02) −0.27 (−0.48 to −0.05) 0.06 0.12 (−0.23 to 0.46) 0.505
Waist (cm) Men
Target: <90 cm
Baseline 176 93.75 ± 9.29 153 92.82 ± 8.49
18 months 139 93.72 ± 8.85 97 90.73 ± 8.11
Mean change from baseline
to 18 months (95% CI)
+0.11 (−0.75 to 0.98) −0.89 (−2.07 to 0.29) 0.20 1.31 (−0.57 to 3.20) 0.172
Waist (cm) Women
Target: <80 cm
Baseline 186 88.57 ± 9.57 176 90.68 ± 10.02
18 months 150 88.67 ± 9.37 122 88.38 ± 8.92
Mean change from baseline
to 18 months (95% CI)
+1.01 (−0.02 to 2.04) −0.90 (−2.28 to 0.48) 0.25 1.38 (−0.74 to 3.49) 0.202
Hip (cm) Men
Baseline 176 102.37 ± 8.69 153 100.23 ± 7.71
18 months 136 101.62 ± 7.68 101 98.51 ± 6.43
Mean change from baseline
to 18 months (95% CI)
−0.43 (−1.42 to 0.56) −0.68 (−1.93 to 0.58) 0.23 1.22 (−0.44 to 2.90) 0.150
Hip (cm) Women
Baseline 186 99.95 ± 8.23 179 102.06 ± 8.81
18 months 155 99.55 ± 7.71 114 98.79 ± 7.99
Mean change from baseline
to 18 months (95% CI)
−0.64 (−1.52 to 0.23) −1.79 (−3.19 to −0.40) 0.21 1.13 (−0.80 to 3.05) 0.252
Systolic BP (mmHg)
Target: <140 mmHg
Baseline 363 129.03 ± 15.14 334 128.46 ± 14.82
18 months 314 127.50 ± 9.95 262 126.86 ± 11.72
Mean change from baseline
to 18 months (95% CI)
−1.99 (−3.74 to −0.24) −1.38 (−3.29 to 0.52) 0.07 −0.16 (−2.96 to 2.65) 0.912
(Continued)
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TABLE 2 | Continued
Intervention group Control group Available cases analysis
Outcomes N Mean ± SD N Mean ± SD ICCa Adjusted difference
between
change scores (95% CI)b
P-value
Diastolic BP (mmHg)
Target: <80 mmHg
Baseline 363 76.91 ± 9.10 334 76.00 ± 8.64
18 months 315 77.20 ± 6.37 265 74.70 ± 8.06
Mean change from baseline
to 18 months (95% CI)
−0.25 (−1.34 to 0.84) −0.51 (−1.79 to 0.76) 0.07 1.01 (−1.36 to 3.39) 0.404
Fasting Plasma Glucose (mmol/L)
Target: 4.4–7.0 mmol/L
Baseline 367 8.27 ± 2.70 330 8.13 ± 2.74
18 months 314 7.47 ± 2.88 260 7.31 ± 2.69
Mean change from baseline
to 18 months (95% CI)
−0.83 (−1.19 to −0.47) −0.98 (−1.37 to −0.59) 0.09 0.30 (−0.36 to 0.96) 0.370
Total Cholesterol (mmol/L)
Target: <4.5 mmol/L
Baseline 363 5.46 ± 1.12 326 5.40 ± 1.19
18 months 314 4.86 ± 1.17 259 4.83 ± 1.07
Mean change from baseline
to 18 months (95% CI)
−0.58 (−0.72 to −0.44) −0.61 (−0.77 to −0.45) 0.02 0.03 (−0.16 to 0.22) 0.748
Triglycerides (mmol/L)
Target: <1.7 mmol/L
Baseline 363 1.91 ± 1.53 326 1.82 ± 1.43
18 months 314 1.59 ± 1.05 259 1.69 ± 1.62
Mean change from baseline
to 18 months (95% CI)
−0.34 (−0.50 to −0.17) −0.20 (−0.37 to −0.03) – −0.06 (−0.23 to 0.11) 0.509
LDL Cholesterol (mmol/L)
Target: <2.6 mmol/L
Baseline 367 3.70 ± 1.21 329 3.56 ± 1.13
18 months 314 3.18 ± 1.05 259 3.07 ± 0.90
Mean change from baseline
to 18 months (95% CI)
−0.53 (−0.67 to −0.39) −0.55 (−0.70 to −0.40) 0.20 −0.00 (−0.18 to 0.17) 0.979
HDL Cholesterol (mmol/L) Men
Target: >1.0 mmol/L
Baseline 178 1.04 ± 0.31 151 1.08 ± 0.27
18 months 146 1.20 ± 0.30 117 1.23 ± 0.27
Mean change from baseline
to 18 months (95% CI)
+0.18 (0.13 to 0.23) +0.16 (0.10 to 0.22) 0.24 0.01 (−0.06 to 0.08) 0.706
HDL Cholesterol (mmol/L) Women
Target: >1.3 mmol/L
Baseline 189 1.17 ± 0.35 179 1.17 ± 0.32
18 months 168 1.25 ± 0.30 142 1.27 ± 0.27
Mean change from baseline
to 18 months (95% CI)
+0.09 (0.04 to 0.14) +0.11 (0.05 to 0.16) 0.33 0.02 (−0.06 to 0.10) 0.569
Where relevant, treatment targets for each outcome are provided to assist the interpretation of values. With the exception of HDL cholesterol, lower scores indicate improvement.
a ICC, intracluster correlations indicated with a “–” were truncated at zero.
bDifferences between groups were estimated by multilevel regression, adjusting for clustering and baseline covariates of age group (<60 years/≥60 years), gender (male/female),
chronic comorbidity category (diabetes only/diabetes plus other/s), time since diabetes diagnosis (<5 years/5–9 years/10–14 years/≥15 years), education level (primary school or
less/secondary or high school/tertiary education), and residential address socioeconomic status (Developed areas/Developing areas/Less developed areas).
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TABLE 3 | Psychological and self-care outcomes at baseline and 18 months by study group.
Intervention group Control group Available cases analysis
Outcomes N Mean ± SD N Mean ± SD ICC Adjusted difference
between
change scores (95% CI)a
P-value
PSYCHOLOGICAL DISTRESS (SCORE RANGE 10–50; RISK CATEGORIES <20 NO/LOW; 20–24 MILD; 25–29 MODERATE; 30–50 SEVERE)
Baseline 362 15.31 ± 6.85 328 14.97 ± 6.24
18 months 310 16.98 ± 5.92 263 15.10 ± 5.59
Mean change from baseline
to 18 months (95% CI)
+1.72 (0.80 to 2.63) +0.30 (−0.66 to 1.26) 0.20 0.56 (−2.19 to 3.31) 0.688
DIABETES MANAGEMENT SELF-EFFICACY (SCORE RANGE 0–200)
Baseline 366 159.32 ± 32.99 334 158.96 ± 34.85
18 months 311 155.69 ± 31.68 261 158.46 ± 28.05
Mean change from baseline
to 18 months (95% CI)
−4.90 (−9.32 to −0.48) −2.74 (−7.42 to 1.95) 0.16 8.28 (−7.42 to 23.98) 0.301
SUMMARY OF DIABETES SELF-CARE ACTIVITIES (SCORE RANGES 0–7; REPRESENTING NUMBER OF DAYS ACTIVITY IS PERFORMED)
General Diet
Baseline 368 5.37 ± 1.80 337 5.44 ± 1.85
18 months 314 5.33 ± 1.37 263 5.50 ± 1.31
Mean change from baseline
to 18 months (95% CI)
−0.07 (−0.30 to 0.16) −0.08 (−0.35 to 0.18) 0.16 0.21 (−0.31 to 0.73) 0.432
Specific Diet
Baseline 368 4.10 ± 1.51 337 4.37 ± 1.62
18 months 314 4.10 ± 1.12 263 4.29 ± 1.22
Mean change from baseline
to 18 months (95% CI)
−0.01 (−0.22 to 0.20) −0.12 (−0.36 to 0.13) 0.11 −0.22 (−0.61 to 0.18) 0.276
Exercise
Baseline 369 5.27 ± 2.07 337 5.01 ± 2.13
18 months 314 5.11 ± 1.74 263 5.07 ± 1.86
Mean change from baseline
to 18 months (95% CI)
−0.21 (−0.47 to 0.05) −0.11 (−0.41 to 0.19) 0.08 −0.06 (−0.57 to 0.46) 0.830
Blood Glucose Monitoring
Baseline 366 1.46 ± 1.75 336 1.85 ± 1.83
18 months 313 2.34 ± 1.90 263 2.56 ± 1.97
Mean change from baseline
to 18 months (95% CI)
+0.78 (0.50 to 1.06) +0.73 (0.42 to 1.03) 0.09 0.03 (−0.62 to 0.69) 0.920
Foot Care
Baseline 368 4.50 ± 2.79 337 4.46 ± 2.62
18 months 313 4.80 ± 2.42 263 5.30 ± 2.11
Mean change from baseline
to 18 months (95% CI)
+0.25 (−0.09 to 0.60) +0.84 (0.46 to 1.22) 0.10 0.19 (−0.78 to 1.15) 0.706
QUALITY OF LIFE (SCORE RANGE FOR EACH DOMAIN 0–100)
Physical Domain
Baseline 368 62.62 ± 12.92 338 63.31 ± 13.99
18 months 314 59.55 ± 11.30 263 62.65 ± 13.21
Mean change from baseline
to 18 months (95% CI)
−3.09 (−4.75 to −1.43) −1.56 (−3.46 to 0.34) 0.08 −0.36 (−4.79 to 4.08) 0.875
Psychological Domain
Baseline 368 68.87 ± 14.45 336 67.90 ± 16.18
18 months 313 61.48 ± 15.71 263 67.16 ± 14.64
Mean change from baseline
to 18 months (95% CI)
−7.69 (−9.94 to −5.44) −1.88 (−4.31 to 0.55) 0.21 −4.16 (−10.98 to 2.66) 0.232
(Continued)
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TABLE 3 | Continued
Intervention group Control group Available cases analysis
Outcomes N Mean ± SD N Mean ± SD ICC Adjusted difference
between
change scores (95% CI)a
P-value
Social Relationship Domain
Baseline 368 64.18 ± 13.95 338 64.82 ± 14.23
18 months 313 62.55 ± 13.63 263 65.49 ± 13.24
Mean change from baseline
to 18 months (95% CI)
−1.67 (−3.88 to 0.54) +0.90 (−1.31 to 3.12) 0.12 −0.52 (−4.96 to 3.92) 0.818
Environment Domain
Baseline 368 65.41 ± 14.53 338 63.72 ± 15.95
18 months 314 59.80 ± 16.40 263 63.81 ± 14.27
Mean change from baseline
to 18 months (95% CI)
−5.72 (−7.99 to −3.45) −0.48 (−2.79 to 1.83) 0.18 −3.55 (−9.43 to 2.33) 0.237
Score ranges for each outcome are provided to assist the interpretation of values. With the exception of psychological distress (K10), higher scores indicate improvement in outcome.
aDifferences between groups were estimated by multilevel regression, adjusting for clustering and baseline covariates of age group (<60 years/≥60 years), gender (male/female),
chronic comorbidity category (diabetes only/diabetes plus other/s), time since diabetes diagnosis (<5 years/5–9 years/10–14 years/≥15 years), education level (primary school or
less/secondary or high school/tertiary education), and residential address socioeconomic status (Developed areas/Developing areas/Less developed areas).
cholesterol for men); and the within-group deteriorations in
mean values for psychological and self-care outcomes for
participants in the control group (i.e., psychological distress)
were not representative of a clinical shift in risk categories.
Clinical significance could be argued for the improvements
observed in systolic BP among intervention group participants
and improvements in triglycerides among participants in both
treatment groups. However, the objectivity of triglyceride levels
as a clinically relevant outcome is debatable (28); and the
clinical significance of systolic BP improvements <140 mmHg is
unclear (29).
The clinically significant improvement in HbA1c among
both treatment groups may partially be explained by the
regular clinical monitoring and resultant feedback to participants
following each clinical health assessment. Most individuals with
T2DM in China do not regularly attend specific appointments
to manage their condition. The Diabcare-Asia (China) study
determined that only 50% of patients with diagnosed DM had
a HbA1c test in the preceding 12-months (30), despite Chinese
diabetes guidelines prescribing biannual HbA1c assessments (7).
Precise health service utilization records were unable to be
retrieved for the time-period before the present study, but the
numerous physiological outcomes with mean values outside
optimal ranges at baseline (in particular HbA1c >10%) indicates
that both groups of participants were either not accessing
CHSs for T2DM management; were not fully adherent to
the T2DM self-care regimen; or were experiencing suboptimal
T2DM care prior to participation in this study. Participation
in this trial required individuals to undergo health checks at
more regular intervals than that outlined in the usual care
recommendations. By informing participants of their T2DM
health status on a more regular basis, it may have motivated
individuals and their healthcare professionals to be more
attentive to their health than otherwise expected, thus modifying
“usual care.”
Furthermore, to maximize participation, medical fees
associated with participation in the present study were waived
for both treatment groups, further modifying the “usual care”
condition. Out-of-pocket healthcare costs are a well-documented
barrier to the accessibility and satisfaction of healthcare services
in China (31). Out-of-pocket costs are also higher for older
(>60 years), retired individuals who are not eligible for the
Urban Employee Basic Medical Insurance scheme (22). As
>90% of participants in the present study were retired at
baseline, the majority of study participants would usually
have been required to incur significant out-of-pocket costs to
manage their T2DM. Possible consequences of the adjustments
to usual care may have been improvement in adherence to
the T2DM self-care regimen; increased CHS attendance; as
well as the initiation of medication to manage uncontrolled
variables.
A further explanation for the comparable improvement
in HbA1c within both treatment groups is the possible
contamination between clusters. Although every effort
was made to prevent contamination, the trial received
considerable media attention during the intervention
phase, which might have contributed to participants and
health coaches altering their usual behavior. Furthermore,
all participating CHSs are administered and managed
by the Fengtai Health Bureau. This was an unavoidable
circumstance of the study setting but is one that may have
affected and blurred the delivery of the intervention and
control procedures. Lastly, the “Hawthorne Effect,” typically
described as the human tendency to improve performance
because of the awareness of being studied (32), may also have
contributed to the improvements noted in both treatment
groups.
The lack of clinical relevance for the statistically significant
findings were primarily due to the small magnitude of changes
for each of the secondary outcomes. The small extent of
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improvements observed in the present trial may be related to
the pragmatic nature of the trial. The broad eligibility criteria
that was utilized resulted in a diverse population of individuals
with T2DM that more closely represents typical clinical
practice in China. The resulting heterogeneity of participants
could have diluted the observed treatment effects which can
occur in pragmatic trials (33). Additionally, the potential
variability of intervention delivery between each CHS, and
the abovementioned considerations of possible contamination
between intervention and control CHSs may have further
contributed to a dilution of treatment effect. If this study
utilized a traditional RCT design under heightened experimental
conditions, observed treatment effects may have potentially been
larger.
To date, no cluster RCTs in China have examined the effect of
health coaching based on MI principles for the management of
individuals with T2DM. A recent systematic review and meta-
analyses identified five studies that utilized MI, all of which
adopted a traditional RCT design (12). As previously noted, the
effects of these studies provide some evidence to support the
use of MI for the improvement of glycemic control in patients
with T2DM; however studies primarily assessed outcomes at 6
months; validity, as assessed through the risk of bias was unclear
for the majority of studies; and baseline HbA1c values were
lower (7–8%) than that observed in the present study (>10%).
Additionally, only two (14, 17) of the five studies were conducted
within a community health setting [one of which assessed HbA1c
(14)]. These clinical and methodological variations consequently
impede the ability for meaningful comparisons to be drawn
between the present study and those previously conducted in
China.
Internationally, three cluster RCTs have assessed the
effectiveness of MI for the improvement of T2DM-related
outcomes (34–36). The between-group findings observed in all
three trials are largely consistent with that observed in the present
study, with no differential treatment effects observed. Despite the
limited number of international cluster RCTs published, several
traditional RCTs have been conducted in international settings
that have assessed the effectiveness of MI for the management
of T2DM-related outcomes. Some of these studies have observed
a differential treatment effect favoring the intervention with
regard to glycaemic control (37), fat intake (38, 39), physical
activity (38), weight (40), waist circumference (38), systolic BP
(41), DM self-care activities (42), and DM-related knowledge
(43). However, for the majority of outcomes in the majority
of studies, differential treatment effects have not been found
(36, 37, 43, 44); a result similar to that observed in the present
trial.
A key strength of the present study was that it was
implemented as a pragmatic trial, specifically tailored to be
delivered in real world CHSs in urban China, hence maximizing
external validity. The cluster design minimized contamination
between CHSs, and stratification and randomization procedures
for both participants and CHSs minimized selection bias and
increased generalizability of the results to other populations of
patients with T2DM in urban China.
A limitation of the present study is that intervention fidelity
has not been adequately assessed as yet; hence, we have not been
able to distinguish between participants with respect to quality
of MI received. In the current trial, it is possible that health
coaches had not reached an appropriate standard to be effective
MI health coaches, despite increasing their skills. All coaching
sessions were audio-recorded throughout the 18-month trial and
future research is planned for the analysis of treatment integrity.
Until this piece of work is performed, it would be unjustified to
conclude that MI is ineffective in the management of T2DM in
China.
The pragmatic design also caused data collection to be
performed by multiple data collectors from all CHSs. While all
data collectors were received extensive training on the study
protocol, quality of data varied, resulting in higher levels of
missing data than expected. Additionally, outcome assessors were
not blinded in the present study. While the lack of blinding
in pragmatic trials can lead to reduced internal validity; the
external validity is enhanced, and consequently improves the
generalizability of findings to clinical settings in which they
would be applied (33).
Despite the noted limitations, and the lack of differential
treatment effects observed, important implications can be drawn
from the findings of the present study. The comparable shift
in mean HbA1c among both groups from >10% at baseline to
within the optimal range of <7% at 18-months is a clinically
relevant outcome that promotes the establishment of free, regular
clinical health assessments for individuals with T2DM in China.
The establishment of such a monitoring program would also
fit within the current healthcare reform, which aims to address
inequitable access to healthcare services. Existing evidence
indicates that healthcare insurance can improve the health
outcomes of some population subgroups in China, including
those of older people (45). Given that older people are associated
with the highest burden of T2DM cases in China, and are more
likely to be retired with limited finances, this population group
would particularly benefit from regular monitoring that is free of
cost.
In all countries, we are struggling with the effective
management of chronic disease. To date, there is little evidence
globally for the long-term success of large-scale interventions
applying behavioral management of diabetes. However, we
must keep researching this important area in order to
alleviate the large burden of disease resulting from sub-optimal
diabetes management. This study represents a foundational step
toward the implementation of rigorously designed psychological
interventions in China, specifically targeting T2DM. Given
the combination of China’s increasing burden of T2DM and
the governments’ strong commitment to healthcare reform,
the opportunities for meaningful contributions in the field
of chronic disease management in China are manifest. The
Chinese government and Chinese Medical Association are
striving to adopt best practice medical management and the
continued examination of the effectiveness of psychological
interventions in T2DM management is a worthy and important
element.
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